GHRL and Parkinson disease: These findings suggest that ghrelin and ghrelin receptor activation are protective in models of PD, an effect that might be mediated by the stimulation of AMP-activated protein kinase (AMPK) activity [33], the enhancement of mitochondrial bioenergetics [29], or the inhibition of microglial activation [32].